Gabriela López-Molina

Dr. Gabriela López-Molina

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
LCLizeth León Carreño
Lizeth León Carreño
DRDaniel Andes Pardo Rodriguez
Daniel Andes Pardo Rodriguez
ARAndrea Del Pilar Hernández Rodriguez
Andrea Del Pilar Hernández Rodriguez
JRJuliana Ramírez-Prieto
Juliana Ramírez-Prieto
GLGabriela López-Molina
Gabriela López-Molina
AOAlejandro Ondo-Mendez
Alejandro Ondo-Mendez
Breast cancer (BC) is a neoplasm characterized by high heterogeneity and is influenced by intrinsic molecular subtypes and clinical stage, aspects that remain underexplored in the Colombian population. This study aimed to characterize metabolic alterations associated with subtypes and disease progression in a group of newly diagnosed, treatment-naive Colombian women using an untargeted metabolomics approach. To improve metabolite coverage, samples were analyzed using LC-QTOF-MS and GC-QTOF-MS, along with amino acid profiling. The Luminal B subtype exhibited elevated levels of long-chain acylcarnitines and higher free fatty acid concentrations than the other subtypes. It also presented elevated levels of carbohydrates and essential glycolytic intermediates, suggesting that this subtype may adopt a hybrid metabolic phenotype characterized by increased glycolytic flux as well as enhanced fatty acid catabolism. Tumor, Node, and Metastasis (TNM) staging analysis revealed progressive metabolic reprogramming of BC. In advanced stages, a sustained increase in phosphatidylcholines and a decrease in lysophosphatidylcholines were observed, reflecting lipid alterations associated with key roles in tumor progression. In early stages (I-II), plasma metabolites with high discriminatory power were identified, such as glutamic acid, ribose, and glycerol, which are associated with dysfunctions in energy and carbohydrate metabolism. These results highlight metabolomics as a promising tool for the early diagnosis, clinical follow-up, and molecular characterization of BC.

18 April 2019 in Latin american journal of clinical sciences and medical technology
Verified
Journal Article
Open access
EDGAR LÓPEZ LÓPEZEDGAR LÓPEZ LÓPEZ
EDGAR LÓPEZ LÓPEZ
AMAriel Delgado Monzón
Ariel Delgado Monzón
AGAngie Carolay Forero Giron
Angie Carolay Forero Giron
NANery M. Aguilar
Nery M. Aguilar
SVSara T. R. Velasquez
Sara T. R. Velasquez
MRMontserrat Escobar Rosales
Montserrat Escobar Rosales
The Lindau Nobel Laureate Meeting 2025 (LINO25) brought together more than 30 laureates and 600 young scientists in the field of chemistry from over 100 countries. One of the most remarkable contributions came from Latin America, with 24 young researchers from seven countries showcasing the high level, commitment, and diversity of science in the region. This special article documents the experience and contributions of this delegation, highlights their active role in scientific debates, their attainment of Nobel Alumni status, and their key recommendations for future generations. In addition, it provides a practical guide on the nomination process, logistical preparation, and strategies to maximize the experience during the event. Finally, it underlines the importance of increasing Latin America's visibility and strengthening its representation, including countries that have historically been underrepresented, in high-impact international scientific spaces such as Lindau.

23 July 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MFManuel G. Forero
Manuel G. Forero
LMLaura A. Medina
Laura A. Medina
APAndrés Felipe Patiño-Aldana
Andrés Felipe Patiño-Aldana
AHAndrea Del Pilar Hernandez-Rodríguez
Andrea Del Pilar Hernandez-Rodríguez
GLGabriela López-Molina
Gabriela López-Molina
AOAlejandro Ondo-Mendez
Alejandro Ondo-Mendez
Background and Objective: The heterogeneous response of cancer cells to radiation necessitates comprehensive investigations into cell survival, which are often conducted using clonogenic assays. These assays involve laborious and subjective manual enumeration of cell colonies. This paper presents an innovative digital image processing technique for automated cell colony counting. Methods: This research focused on HT-29 cells (colon cancer). The methodology uses Hough techniques to achieve precise detection, mathematical morphology, and establishment of the optimal minimum colony size using ROC curve. This approach seamlessly integrated into ImageJ software as a ColCounter plugin. Results: Images with resolution of 1200*1200 pixels achieved sensitivity and specificity of 92.88% and 92.62%, respectively. To determine the software´s effectiveness of image analysis of different resolutions compared with manual counting, an evaluation of the automated method’s reliability was conducted. The findings revealed an overall intraclass correlation coefficient (ICC) of 0.89 (95% CI: 0.81–0.93). The limits of agreement were determined using the Bland-Altman method. Conclusions: The proposed methodology demonstrated interchangeability with the conventional manual enumeration technique. The results confirm the software’s elevated performance, even in altered contexts. ColCounter offers manual editing function, enhancing its utility as a streamlined, rapid, and precise tool for quantifying tumor cell colonies in clonogenic assays.

26 February 2026 in Repertorio de Medicina y Cirugía
Verified
Journal Article
Open access
XEXimena Palacios Espinosa
Ximena Palacios Espinosa
ÁRÁngela María Ruiz-Sternberg
Ángela María Ruiz-Sternberg
HRHanna Valentina Tovar Romero
Hanna Valentina Tovar Romero
GLGabriela López-Molina
Gabriela López-Molina
JAJesús William Ramos Anaya
Jesús William Ramos Anaya
APAngela María Pinzón-Rondón
Angela María Pinzón-Rondón
Objective: to describe self-medication prevalence and associated factors amidst the COVID-19 pandemic in a university community in Bogotá, Colombia. Materials and methods: a cross-sectional study in 706 adult subjects, applying an online survey to assess self-medication, medications use, complementary therapies, and clinical and sociodemographic variables. Results: subjects aged between 18 and 80 years (mean: 30.47). About 70% of participants were women and more than half were university students. Self-medication prevalence was 65.3%, 37.7% used medication and 49.9% used complementary and popular therapies. Medication was associated with chronic disease (OR=1.64; 95% CI 1.08-2.51), and adulthood (OR=2.88; 95% CI 1.02-8.14). The use of therapies predominated in females (OR=2.07, 95% CI 1.48-2.90) and low (OR=2,76; 95% CI 1.54-4.95) and medium (OR=2.24; CI 95% 1.50-3.35) socioeconomic strata. Discussion: self-medication prevalence amidst the COVID-19 pandemic was high, higher than what is reported in other studies. However, comparison should be cautious due to information heterogeneity in terms of population, self-medication definition, recall period, studies context, surveyed products and practices and social desirability of survey respondents. Conclusions: the need to develop robust drug control and health education public policies, for promoting responsible self-care alternatives, was evidenced.